The holding company for
biological products and vaccines VACSERA started,since 1881,a long journey of
disease prevention and vaccine production.
The beginning was the small pox vaccine, produced for the first time in Egypt
in 1893.Now the Holding Company for Biological Products and Vaccines (VACSERA)
is completing the journey through five affiliated companies namely:
EGYVAC(The Egyptian Company for production of
vaccines, sera and drugs).
EGYTEC (Egyptian Company for Biotech industries)
EGYBLOOD (Egyptian company for Blood transfusion
services)
EGYVET (Egyptian company for drugs&veterinary
products)
Diagsera (Egyptian company for diagnostics)
With a history of more
than 120 years as well as an excellent and reliable supply of high-quality
vaccines,antisera,biological products and drugs,VACSERA is moving onwards
serving millions of customers every year in Egypt and neighboring countries.
Those products are complying with GMP international standards.VACSERA fulfill
two WHO reference laboratories standards (Influenza isolation Lab. and Enteric
virus isolation Lab.).Vacsera core strategy is to create value by rapidly
developing and successfully marketing vaccines and drugs that satisfy the needs
in large population. We focus on delivering effective and cost- efficient
healthcare solutions, at a time of dramatic technological advances and
challenging economics.
